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Abstract
Both CD28 and NKG2D can function as co-stimulatory receptors in human CD8
+ T cells. However, their independent
functional contributions in distinct CD8
+ T cell subsets are not well understood. In this study, CD8
+ T cells in human
peripheral blood- and lung-derived lymphocytes were analyzed for CD28 and NKG2D expression and function. We found a
higher level of CD28 expression in PBMC-derived naı ¨ve (CD45RA
+CD27
+) and memory (CD45RA
2CD27
+) CD8
+ T cells
(CD28
Hi), while its expression was significantly lower in effector (CD45RA
+CD27
2) CD8
+ T cells (CD28
Lo). Irrespective of the
differences in the CD28 levels, NKG2D expression was comparable in all three CD8
+ T cell subsets. CD28 and NKG2D
expressions followed similar patterns in human lung-resident GILGFVFTL/HLA-A2-pentamer positive CD8
+ T cells. Co-
stimulation of CD28
Lo effector T cells via NKG2D significantly increased IFN-c and TNF-a levels. On the contrary, irrespective
of its comparable levels, NKG2D-mediated co-stimulation failed to augment IFN-c and TNF-a production in CD28
Hi naı ¨ve/
memory T cells. Additionally, CD28-mediated co-stimulation was obligatory for IL-2 generation and thereby its production
was limited only to the CD28
Hi naı ¨ve/memory subsets. MICA, a ligand for NKG2D was abundantly expressed in the tracheal
epithelial cells, validating the use of NKG2D as the major co-stimulatory receptor by tissue-resident CD8
+ effector T cells.
Based on these findings, we conclude that NKG2D may provide an expanded level of co-stimulation to tissue-residing
effector CD8
+ T cells. Thus, incorporation of co-stimulation via NKG2D in addition to CD28 is essential to activate tumor or
tissue-infiltrating effector CD8
+ T cells. However, boosting a recall immune response via memory CD8
+ T cells or vaccination
to stimulate naı ¨ve CD8
+ T cells would require CD28-mediated co-stimulation.
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Introduction
CD28 and NKG2D can function as co-stimulatory receptors in
CD8
+ T cells [1]. However, their functional contribution in T cell
activation is not well understood. NKG2D is an important
activating receptor of NK cells [2] and has been defined as a co-
stimulatory molecule for TCR- ab and TCR-cd CD8
+ T cells [1].
In humans, the ligands for NKG2D are major histocompatibility
class I-related chain A/B (MICA/B) and UL-16 binding proteins
1–4 (ULBP1-4). ULBP4 is also known by the other name
lymphocyte effector cell toxicity-activating ligand, LETAL [3].
While ULBP 1,2 and 3 are GPI-linked proteins, the more
divergent LETAL is a transmembrane protein [4,5]. Ligand
expression is restricted or absent on normal tissues but is induced
in response to various stresses and in some pathological conditions
including epithelial-derived tumors [6]. In human T cells,
NKG2D exclusively associates with DAP10 and not DAP12 and
its co-stimulation enhances proliferation, survival, expression of
activation markers and production of IFN-c, TNF-a and IL-2
[7,8]. However, NKG2D-mediated activation of CD8
+ T cell
effector functions in the absence of CD3-mediated stimulation is
controversial [8,9]. Earlier studies suggest that activated cytotoxic
T lymphocytes (CTLs), intra-epithelial lymphocytes (IELs) and cd
T cells could trigger cytotoxicity through NKG2D stimulation
alone, although this was insufficient to generate cytokine
production [10]. Other studies show that NKG2D does not co-
stimulate proliferation, cytotoxicity or cytokine production in
naı ¨ve or activated human CTL [11]. These contradictory findings
indicate that the role of NKG2D in regulating CD8
+ T cell
effector functions is not fully understood.
CD28 recognizes the B7 family of ligands (B7.1-CD80, B7.2-
CD86, ICOS-L, PD-L1, PD-L2, B7-H3 and B7-H4). Interaction
of CD28 with CD80 and CD86 are critical for naı ¨ve CD8
+ T cell
activation [12]. CD28 recruits PI3K-p85a through its cytoplasmic
YMNM motif and synergizes with TCR/CD3-mediated signaling
cascades [13]. Earlier studies have shown that a co-stimulation via
CD28 is essential for IL-2 production and IL-2Ra (CD25)
expression [14]. CD28 is also known to regulate the threshold of
TCR-mediated activation and significantly reduce the number of
TCR-epitope/MHC interactions needed to promote the prolifer-
ation, clonal expansion, differentiation and survival of T cells [15].
CD28 co-stimulation can also augment the expression of Bcl-xL,a
key cell survival molecule that prevents the induction of apoptosis
[16]. CD8
+ T cells can be divided into CD28 low (CD28
Lo) and
CD28 high (CD28
Hi) subsets. In particular, using phenotypic
markers, the CD28
Lo subset has been determined to be effector,
while the CD28
Hi subset as naı ¨ve/memory CD8
+ T cells [8]. A
dichotomy in the CD28 expression and a functional requirement
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CD28
Lo effector T cells is not well understood.
In this study, we found that the expression of NKG2D was not
altered among CD8
+ T cell subsets. However, NKG2D but not
CD28 functioned as an essential co-stimulatory receptor in
human peripheral blood mononuclear cell (PBMC)-derived
CD28
LoCD45RA
+CD27
2 CD8
+ effector T cell population.
CD28 expression was high in naı ¨ve/memory CD8
+ T cells,
where it worked as the primary co-stimulatory molecule.
Differences in the expression pattern of CD28 were also observed
in the lung-resident influenza-specific CD8
+ T cell subsets.
Uniquely, effector CD8
+ T cells generated a higher level of IFN-c
and TNF-a in response to NKG2D-mediated co-stimulation.
Conversely, irrespective of its normal expression, NKG2D did
not co-stimulate the generation of IFN-c,T N F - a or IL-2 in
CD28
Hi memory CD8
+ T cells. For IL-2 generation, CD28-
mediated co-stimulation was obligatory and its production was
limited only to the CD28
Hi naı ¨ve/memory subsets. MICA was
abundantly expressed within the tracheal epithelial cells. These
results provide critical insights into the functional dichotomy of
co-stimulatory receptors in distinct CD8
+ T cells.
Results
Differential expression of CD28 and NKG2D in human
CD8
+ T cells
CD28 and NKG2D have co-stimulatory functions in T cells (9–
12). Both CD28 and NKG2D/DAP10 recruit PI3K to propagate
their signals. However, a functional necessity for T cells to express
two similar co-stimulatory receptors is not well understood.
Moreover, qualitative differences between NKG2D and CD28-
mediated co-stimulation in cytokine production are yet to be
defined. To understand the differential abilities of these two co-
stimulatory receptors, we first analyzed their expression patterns.
Human PBMC-derived CD3
+CD8
+ and CD3
+CD4
+ T cells
(N=30) revealed that the majority of the CD8
+ T cells expressed
higher levels of NKG2D and its expression in CD4
+ T cells was
low (Figure 1A). The difference in the expression of NKG2D
Figure 1. Expression of NKG2D and CD28 on human CD3
+CD4
+ and CD3
+CD8
+ T cells. A) Analysis of NKG2D expression on CD3
+CD4
+ and
CD3
+CD8
+ T cells by flow cytometry. Human PBMC were stained for CD3, CD4 or CD8 along with NKG2D or CD28. Background isotype control (open
histograms) and NKG2D (grey histograms) stainings are shown. The mean fluorescence index (MFI) for NKG2D (N=30) among the CD3
+CD4
+ and
CD3
+CD8
+ T cells were compared and presented in the right panel. B) Similar analysis was performed for the expression of CD28 on CD3
+CD4
+ and
CD3
+CD8
+ T cells. Open histograms represent negative controls. Since the expression of CD28 on CD8
+ T cells was biphasic, a comparison of the
percentage of CD28
HiCD4
+ and CD28
HiCD8
+ T cells was performed (N=30). C) CD28 expression among CD3
+CD8
+ T cells falls into two distinct
subsets. Differences between the MFI of CD28
Hi and CD28
LoCD8
+ T cells are shown. D) Co-expression of CD28 and NKG2D in CD3
+CD8
+ T cells.
E) Confocal microscopy analyses of the expression of CD28 and NKG2D on CD4
+ and CD8
+ T cells. PBMC were either stained for CD4 or CD8. They
were also stained for CD28 and NKG2D. The stained cells were visualized by confocal microscopy and expression of each receptor was visualized
individually and merged. Arrow heads indicate limited positivity of NKG2D in CD4
+ T cells. P values for A–C were calculated using Student’s t-test.
doi:10.1371/journal.pone.0012635.g001
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(Figure 1A;P ,0.001). The majority of the PBMC-derived
CD3
+CD4
+ T cells uniformly expressed CD28 at a high level
(Figure 1B; N=30). However, CD28 expression in CD8
+ T cells
followed a biphasic pattern with the CD28 high population
(CD28
Hi) ranging from 25 to 80% (Figure 1B;P ,0.001).
Remaining CD8
+ T cells expressed lower levels of CD28
(CD28
Lo). The difference in the mean fluorescence index (MFI)
of CD28 between the CD28
Lo and CD28
Hi T cells was significant
(Figure 1C;P ,0.0001). In contrast, expression of NKG2D did
not vary between the CD28
Hi and CD28
Lo CD8
+ T subsets
(Figure 1D). Expression of CD28 and NKG2D in PBMC-derived
CD4
+ and CD8
+ T cells were further confirmed by confocal
microscopy (Figure 1E). Our results indicate both CD4 and CD8
T cells expressed CD28. However, the constitutive expression of
NKG2D could be observed only in the CD8
+ T cells.
The functional status of CD8
+ T cells is determined by
CD28 but not NKG2D expression
To further understand the expression patterns of NKG2D and
CD28, PBMC-derived CD8
+ T cells were separated based on their
functional status using CD45RA and CD27 receptor expression.
CD8
+ T cells were negatively selected, stained and phenotypically
separated into naı ¨ve (CD45RA
+CD27
+),effector (CD45RA
+CD27
2)
and memory (CD45RA
2CD27
+)Tc e l l s( Figure 2A). These subsets
were analyzed for NKG2D and CD28 expression. Our results
indicate that there were no differences in the expression of NKG2D
between the naı ¨ve, effector and memory CD8
+ T cells (Figure 2B).
However, the expression of CD28 was found to be significantly high
on the memory CD8
+ Tc e l l s .N a ı ¨ve CD8
+ T cells expressed
moderate levels of CD28. The effector CD8
+ T cells expressed the
leastamountofCD28whencompared tothe memory(P=0.0015)or
naı ¨ve (P=0.01) CD8
+ Tc e l l s( Figure 2C). These differences
were statistically significant and indicate a possible functional
role for NKG2D in CD8
+ effector T cells.
Human lung-resident, antigen-specific effector CD8
+ T
cells express lower levels of CD28
Since lymphocytes derived from the PBMC may not represent
the functional status of T cells in the tissue environment, we
extended our analyses to human lung-derived CD8
+ T cells. We
obtained lung tissues from cadaveric organ donors. Lymphocytes
were isolated and the expression levels of NKG2D and CD28 were
analyzed on CD8
+ T cells. Phenotypic separation based on
CD45RA and CD27 helped to separate the naı ¨ve, effector and
memory CD8
+ T cells (Figure 3A). Analyses in multiple individuals
Figure 2. Expression of CD28 but not NKG2D is low in the PBMC-derived CD45RA
+CD27
2 effector CD8
+ T cells. A) CD3
+CD8
+ T cells
were classified into naı ¨ve, effector and memory subsets based on their CD27 and CD45RA expression. B) Flow cytometry analysis of the expression of
NKG2D and C) CD28 in the effector, naı ¨ve and memory CD8
+ T cells. Histograms in B and C (open-effector, grey-naı ¨ve and black-memory) depict the
expression of NKG2D and CD28 in the different functional subsets of CD8
+ T cells. Dashed line histograms represent negative controls. Nine
independent samples were used to obtain data presented in B and C. P values were calculated using Student’s t-test.
doi:10.1371/journal.pone.0012635.g002
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+CD27
2effec-
tor CD8
+ T cells expressed a lower level of CD28 while its level was
significantly higher in CD45RA
+CD27
+ naı ¨ve (P=0.003) and
CD45RA
2CD27
+ memory (P=0.005) CD8
+ T cells (Figure 3B).
However, no such differences were seen in the levels of NKG2D
expression among these subsets. Based on these results, we conclude
that NKG2D may have an expanded co-stimulatory role to play
along with CD28 in CD45RA
+CD27
2 effector CD8
+ T cells.
To investigate whether antigen-specific CD8
+ T cells also show
similar CD28 expression patterns, we stained the lung-derived
lymphocytes with peptide-loaded MHC Class I pentamer
(Figure 4). HLA-A2 positive individuals generate a strong CD8
+
memory T cell response to an immunodominant epitope,
(GILGFVFTL; GFL9), from influenza virus M1 protein [17]. The
frequency of GFL9-specific CD8
+ T cells is high enough to allow
direct visualization using GFL9/HLA-A2 pentamers [18]. There-
fore, we used flow cytometry to analyze antigen-specific CD8
+ T
cells from PBMC andlung-derived lymphocytesusing GFL9/HLA-
A2 pentamer (Figure 4A). This analysis was extended to
cryosections derived from human trachea and lung tissue
(Figure 4B and 4C). Abundant GFL9/HLA-A2 pentamer-
positive CD8
+ T cells could be detected in these cryosections using
confocal microscopy. Staining of tracheal sections consistently
indicated that GFL9/HLA-A2 pentamer-positive T cells preferen-
tially expressed NKG2D. However, the number of CD28
expressing CD8+ cells was lower compared to that of NKG2D
expressing CD8+ T cells (Figure 4B). However, pentamer-positive
T cells in the lung tissue expressed both CD28 and NKG2D
(Figure 4C). Thus, it is possible that trachea contains more effector
CD8
+ T cells while the memory cells home in the lung tissue. To
further determine the subset specific expression of CD28 among
pentamer-positive cells, lung-derived CD3
+CD8
+ T cells were
analyzed for CD45RA, CD27 and CD28 receptors (Figure 4D).
While the PBMC-derived lymphocytic populations contained a
considerable number of CD45RA
+CD27
2 effector T cells
(Figure 4E), lung tissues possessed only a few of this subset and a
higher number of CD45RA
2CD27
+ memory T cells (Figure 4D).
This higher frequency of CD28
Hi memory CD8
+ T cells in the lung
tissue strongly correlated with our confocal data (Figure 4C).
Together, our results show influenza-derived GFL9/HLA-A2-
restricted CD45RA
+CD27
2 effector T cells express lower levels of
CD28 compared to that of CD45RA
2CD27
+ memory T cells.
Based on these results, we conclude antigen-specific, tissue-resident
CD45RA
+CD27
2 CD8
+ T cells express lower levels of CD28
indicating an expanded co-stimulatory role for NKG2D.
MICA is expressed in tracheal epithelial cells
Successful co-stimulation via NKG2D in lung-derived
CD45RA
+CD27
2 effector CD8
+ T cells requires the expression
of ligands at these sites. Human NKG2D recognizes stress-inducible
MICA, MICB and ULBPs [1,19]. Tracheal and lung sections from
human cadavers werestained withanti-MICAantibody. Antibodies
to E-Cadherin and cytokeratin uniquely marked the stratified
columnar epithelial cells in the trachea (Figure 5A) and these cells
showed a strong expression of MICA. Staining of lung tissues also
indicated the presence of MICA positive cells; however, compared
to the tracheal epithelial cells this staining was only moderately
intense (Figure 5B). MICA expression was found both in the cell
surface and intracellularly; with considerable amount of the MICA
restricted to intracellular compartments. MICA found within
epithelial cells co-localized with cytokeratin (Figure 5C). In this
context, it is important to note that the cadaveric donors were not
known to have any respiratory illnesses prior to their death.
Structures below the epithelial layer such as basement membrane,
submucosal layer, areolar and the connective tissue or the cartilage
did not express MICA. While the columnar epithelial cells showed a
relatively uniform intracellular expression of MICA, there were
places where its expression was concentrated in a polarized fashion
(arrow heads). These polarized spots could be seen both on the
apical and basal side of the epithelial cells (Figure 5C).
The number of cells that were MICA positive was fewer in the
lung tissue compared to the trachea. These MICA positive cells
Figure 3. Human lung-derived CD45RA
+CD27
2 effector CD8
+ T cells express low levels of CD28. A) CD3
+CD8
+ T cells were classified into
naı ¨ve, effector and memory cells based on CD27 and CD45RA surface expression. These subsets were analyzed for the expression levels (MFI) of CD28
and NKG2D. B) Comparison of CD28 (left histogram) and NKG2D (right histogram) in effector (open bar), naı ¨ve (grey bar) and memory (black bar)
CD8
+ T cells. Four independent samples were analyzed to obtain data presented in B and the P values were calculated using Student’s t-test.
doi:10.1371/journal.pone.0012635.g003
Dichotomy of NKG2D and CD28
PLoS ONE | www.plosone.org 4 September 2010 | Volume 5 | Issue 9 | e12635were circular and appeared to be lymphoidal. Therefore, we
extended our analyses to lymphocytes. Our results show lung-
derived CD4
+ T cellswere strongly positiveforMICA (Figure5D),
while the CD8
+ T cells were not (Figure 5E). Based on these
results, we conclude that MICA is present in the upper respiratory
tract, albeit intracellularly. We predict a cellular stress such as
influenza infection would initiate the transport of MICA from their
cytoplasmic stores to the basement membrane of epithelial cells.
Thus, CD28
Lo antigen-specific CD45RA
+CD27
2 effector CD8
+ T
cellscanutilizeNKG2Dasa co-stimulatoryreceptorbyrecognizing
MICA on infected tracheal epithelial cells along with antigenic
epitopes presented on MHC class I molecules.
NKG2D plays a critical expanded co-stimulatory role in
CD28
Lo effector CD8
+ T cells for cytokine production
Presence of MICA in the tracheal epithelial cells and the
reduced levels of CD28 in effector CD8
+ T cells suggest an
essential co-stimulatory role for NKG2D at the site of infection.
To determine their independent functional contributions of CD28
and NKG2D, we sorted the total CD3
+CD8
+ T cells from human
PBMC and stimulated them with plate-bound anti-CD3, anti-
CD28 and anti-NKG2D mAb alone or in combinations. Culture
supernatants were tested for the levels of IFN-c, TNF-a or IL-2.
Results presented in Figure 6A–C demonstrate anti-CD3 alone
mediated some levels of IFN-c and TNF-a. Anti-CD28 or anti-
NKG2D mAb alone did not result in any cytokine production
(data not shown). Co-stimulation via CD28 significantly increased
the levels of IFN-c and IL-2 (P=0.003 and 0.01, respectively). Co-
stimulation via NKG2D also increased the levels of IFN-c
production (P=0.03). Combined stimulation via CD28 and
NKG2D along with anti-CD3 significantly augmented the
production of IFN-c (P=0.001) TNF-a (P=0.03) and IL-2
(P=0.01). This expanded effect of CD28 and NKG2D co-
stimulation was evident only when the assay was performed on
Figure 4. Analysis of CD28 expression on influenza-specific (M1 peptide, GFL9) CD8
+ T cells in PBMC and lung. A) Human PBMC and
lung-derived lymphocytes were stained with anti-CD3, anti-CD8 and GFL9/HLA-A2 pentamer to detect antigen-specific CD8
+ T cells. Gated
populations indicate percent GFL9 epitope-specific CD8
+ T cells. CD28 expression is higher in antigen-specific memory CD8
+ T cells. B) GFL9/HLA-A2
pentamer-positive tracheal and C) lung tissue-resident CD8
+ T cells were analyzed for CD28 and NKG2D expression using confocal microscopy. Arrow
heads mark some of the pentamer-positive CD8
+ T cells. D) Lung tissue and E) PBMC were stained for CD27 and CD45RA in order to classify them
into effector and memory cells. These cells were stained with anti-CD28 and GFL9/HLA-A2 pentamer. Histograms show the level of CD28 expression
among the pentamer-positive effector or memory CD8
+ subsets. Numbers in the histograms represent the MFI of CD28 expression.
doi:10.1371/journal.pone.0012635.g004
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+CD8
+ T cells but not total PBMC (data
not shown). This could be attributed to the preferential expression
of NKG2D on CD8
+ over CD4
+ T cells and the relative frequency
of CD8
+ T cells (10–15%) in the total PBMCs. Another possible
explanation could be an increased expression of NKG2D on
CD8
+ T cells in response to CD3/CD28-mediated activation.
However, our results indicated that NKG2D expression levels
remained unchanged with or without stimulation (data not shown).
To determine the functional contributions of CD28 and
NKG2D on CD8
+ T cell subsets, we sorted CD8
+ T cells into
CD28
Lo effector and CD28
Hi memory and tested their ability to
respond to anti-CD28 or anti-NKG2D-mediated co-stimulation in
the presence of anti-CD3 mAb-mediated activation (Figure 6D–
I). Cytokines in the culture supernatants were used as a measure of
co-stimulation. CD28
Lo effector T cells were more efficient in
generating IFN-c (Figure 6D; P=0.04) and TNF-a (Figure 6E;
P=0.027) when co-stimulated through NKG2D receptor. How-
ever, a co-stimulation through CD28 did not result in a significant
increase in the generation of these cytokines when compared to
anti-CD3 mAb-mediated activation alone. CD28
Lo effector T cells
did not generate any IL-2 with anti-CD3 mAb activation
(Figure 6F). Further, neither CD28 nor NKG2D-mediated co-
stimulation could activate IL-2 production in CD28
Lo effector T
cells (Figure 6F).
Interestingly, CD28
Hi memory T cells responded well for
CD28-mediated co-stimulation in generating IFN-c (Figure 6G;
P=0.027), TNF-a (Figure 6H) and IL-2 (Figure 6I; P=0.01).
In particular, CD28
Hi memory T cells generated higher levels of
IL-2 in response to CD28-mediated co-stimulation. A difference
in the ability of CD28 to preferentially co-stimulate CD28
Hi
memory T cells could be logically attributed to the expression
levels of CD28. However, irrespective of the comparable levels of
NKG2D expression between CD28
Lo and CD28
Hi CD8
+ T cells,
the latter minimally responded to NKG2D-mediated co-stimula-
tion (Figure 6G–I). The cytokine productions in the sorted
CD28
Lo or CD28
Hi CD8
+ T cells were consistently higher
compared to that of unsorted CD8
+ T cells. This difference could
be due to a change in the relative frequency of CD28
LoCD8
+ or
CD28
HiCD8
+ T cells after sorting. We also analyzed the
requirement of CD28 or NKG2D-mediated co-simulations in
the release of cytotoxic granules. Human PBMC-derived CD8
+ T
cells were activated with indicated combinations of mAbs and the
granule release was quantified through CD107a expression.
CD28
Hi memory CD8
+ T cells were comparatively less effective
Figure 5. MICA is expressed in human tracheal epithelial cells. Paraffin sections of human A) trachea and B) lung tissue were processed and
stained for MICA and the epithelial cell markers E-Cadherin and cytokeratin. C) Enlarged view of tracheal sections showing the intracellular
localization of MICA (Arrow heads). D) CD4
+ but not E) CD8 T cells express MICA. Lung-derived lymphocytes were stained for CD4
+ and CD8
+ T cells.
CD4
+ and CD8
+ T cells were further stained and analyzed for MICA expression through confocal microscopy. Data shown are one representative
image of seven independent sections analyzed for each lung tissue and trachea.
doi:10.1371/journal.pone.0012635.g005
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Lo effector T cells in expressing CD107a after CD3-
mediated activation (Figure 7). However, CD107a expression
did not differ between different combinations of mitogenic
antibody stimulations in the CD28
Lo effector CD8
+ T cells. In
contrast, co-stimulation via NKG2D (P=0.031), CD28 (P=0.03)
or both (P=0.033) significantly increased the granule release in
the CD28
Hi naı ¨ve/memory CD8
+ T cells. Thus, we conclude
both CD28 and NKG2D-mediated co-stimulations can signifi-
cantly influence the cytotoxicity in CD28
Hi naı ¨ve/memory CD8
+
T cells.
Discussion
NKG2D and CD28 function as major co-stimulatory receptors
in CD8
+ T cells [9]. However, the differential expression of CD28
and the functional relevance of NKG2D in CD28
Lo CD8
+ T
subset are not well understood. Our results indicate that the
expression of CD28 was high in PBMC-derived memory and
naı ¨ve CD8
+ T cells; while, its expression was significantly lower in
effector CD8
+ T cells. This pattern was also observed in human
lung-derived CD8
+ T cell subsets. Expression of NKG2D was
largely comparable among different CD8
+ T cell subsets. These
observations along with the functional data suggest a differential
ability of CD28 and NKG2D in co-stimulating CD8
+ T cells.
These observations for the first time help to establish a functional
dichotomy between NKG2D and CD28 receptors.
A reduction of CD28 expression in the CD45RA
+CD27
2
effector CD8
+ T cells lead to the assumption that the effector T
cells do not require a co-stimulation and activation via CD3/TCR
is sufficient to promote their functions. However, our data
indicating an ample expression of MICA in tracheal epithelial
cells and the presence of NKG2D on effector CD8
+ T cells argue
that this co-stimulatory system can regulate T cell functions at the
site of inflammation. Indeed, our results show that CD28
Lo
effector CD8
+ T cells produced higher levels of IFN-c and TNF-a
in response to NKG2D-mediated co-stimulation. Conversely,
regardless of its normal levels of expression on CD28
Hi CD8
+
naı ¨ve/memory T cells, NKG2D did not augment the production
of these inflammatory cytokines in this T cell subset. Our results
also indicate that anti-CD28 or anti-NKG2D mAb alone did not
result in the production of IFN-c or TNF-a in the total CD8
+ T
cells or the subsets. Thus, our functional data demonstrate that
NKG2D has an expanded co-stimulatory function in the effector
CD8
+ T cells. However, generation of IFN-c and TNF-a in
CD28
Hi naı ¨ve/memory subset required the co-stimulation via
CD28. These observations are supported by earlier studies that
have indicated CD28-negative CD8
+ T cells were more effective
in generating IFN-c during influenza infection [20]. However, this
Figure 6. Efficiency of CD28 and NKG2D co-stimulation in cytokine/chemokine production. Negatively selected CD8
+ T cells (N=10) or
sorted CD28
Lo and CD28
Hi CD8
+ T cells (N=5) were activated with plate-bound antibodies in different combinations. Quantities of IFN-c, TNF-a and
IL-2 were estimated in the culture supernatants using multiplex assays. Cytokine generation from total CD8
+ (A–C), effector CD28
Lo (D–F) and naı ¨ve/
memory CD28
Hi (G–I) CD8
+ T cells are shown. Bar diagram represents the mean 6 standard deviation of cytokine production. P values were
calculated using paired t-test.
doi:10.1371/journal.pone.0012635.g006
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T cell subsets.
NKG2D is a type-II lectin and its cell surface expression
requires its association with DAP10 adaptor protein that contains
a consensus YXXM tyrosine-based motif [21]. CD28 is a type-I
protein and its cytoplasmic tail contains a YINM motif. Activation
via NKG2D or CD28 results in the phosphorylation of protein
tyrosine kinases (PTK). PTKs phosphorylate YXXM or YINM
motifs, which in turn recruits the regulatory subunit of
phosphatidylinositol-3-kinase-p85a (PI3K-p85a) that in associa-
tion with the catalytic subunit PI3K-p110d transduces down-
stream signaling [22,23]. Based on these earlier observations,
immediate downstream signaling components appear to be largely
shared between NKG2D and CD28 receptors. In this context, it is
interesting to note that the generation of IL2 was exclusively
dependent on the co-stimulation mediated via CD28. Co-
stimulation via NKG2D only minimally induced the generation
of IL-2 in effector as well as memory CD8
+ T cells. This
observation highlights the yet unexplored unique molecular
signatures of NKG2D and CD28-mediated activation pathways.
Cell surface expression of CD107a (Lamp1) that represents the
levels cytotoxic granule release did not differ between CD28 and
NKG2D-mediated co-stimulation. Hence, we conclude that the
CD8
+ T cell-mediated cytotoxicity is probably not influenced by
the type of co-stimulation.
MICA, MICB and ULBPs are stress inducible ligands of
NKG2D receptor and they belong to non-classical MHC class I
family [1]. Earlier studies have shown the constitutive expression
of MIC in intestinal and thymic epithelial cells [24,25]. Studies
have also indicated the constitutive expression of NKG2D ligands
in the cytoplasm of human bronchial epithelial cells [26].
However, expression and function of MICs in human tracheal
epithelial cells have not been described. Tracheal epithelial cells
function as the major barrier to viral infections and thereby
become susceptible to influenza virus infections [27]. In the
present study, analyses of tracheal and lung specimens obtained
from human cadavers indicate that similar to intestinal epithelia,
tracheal epithelial cells also constitutively express abundant
intracellular MICA. Yet, we were unable to see any significant
expression of MICA in cells within the lung tissue. Our study
indicates that the MICA was present both on the cell surface and
intracellularly in the tracheal columnar epithelial cells. However, a
considerable amount of MICA was localized intracellularly. This
could be due to the fact that these tissue specimens came from
normal healthy individuals. Cellular distress such as viral infections
could lead to transport of cytoplasmic MICA to the cell surface. It
is also important to note that unlike professional antigen
presenting cells, epithelial cells do not express ligands for CD28
[28]. Interestingly, we also observed expression of NKG2D but
not CD28 in the tracheal-resident GFL9/HLA-A2 pentamer-
positive T cells. Conversely, most of the lung tissue-resident
GFL9/HLA-A2 pentamer-positive T cells were both NKG2D and
CD28 positive. These findings validate the notion that effector
CD8
+ T cells use NKG2D as their preferred co-stimulatory
receptor. Apart from not expressing CD80 or CD86, infected
epithelial cells also generate high concentrations of IL15 that is
known to influence the expression levels of NKG2D in CD8
+ T
cells [9]. Based on these findings, we conclude recognition of cell
surface MICA by CD8
+ effector T cells via NKG2D could
constitute critical co-stimulatory signal that complement the
antigenic peptide/MHC-induced TCR activation at the site of
infection.
Functions of CD28 as a co-stimulatory molecule have been well
established [29,30]. Naı ¨ve and memory CD8
+ T cells that mostly
reside in the lymph nodes (LN) express CD28 along with NKG2D.
During influenza infection, tissue dendritic cells (tDC) acquire viral
antigens, mature and migrate from the upper respiratory tract to
the mediastinal LN, where they activate naı ¨ve influenza specific
CD8
+ T cells [31,32]. Therefore, an increase in the expression of
CD80 and CD86 on CDl1c
+ tDCs is critical to prime via CD28
[33]. The antigen exposure by the dendritic cells converts naı ¨ve T
cells into effectors, which migrate into trachea to kill virally-
infected epithelial cells. At what stage the effector CD8
+ T cells
down regulate CD28 or the molecular mechanism associated with
this process is currently not known.
Efficient activation of CD8
+ T cells is critical to clear tumor or
virally-infected cells. Current vaccination strategies are designed to
generate and maintain robust memory lymphocyte populations. In
contrast, targeted tumor interventions are required to revitalize
inefficient effector T cell populations that have failed to clear
malignant cells. Thus, these two strategies target two distinct T cell
Figure 7. Influence of CD28 and NKG2D-mediated co-stimula-
tion in cytotoxicity. Negatively selected CD3
+CD8
+ T cells were
further sorted based on their CD28 expression levels into CD28
Lo and
CD28
Hi CD8
+ T cells. These cells were activated with plate-bound
antibodies directed against CD3, CD28 and NKG2D in different
combinations. Cell surface expression of CD107a was analyzed through
flow cytometry and used as a measure of cytotoxicity. Three
independent samples were used to obtain data and P values were
calculated using paired t-test.
doi:10.1371/journal.pone.0012635.g007
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activations for their immune responses. Based on the present
study, we conclude incorporation of co-stimulation via NKG2D
along with CD28 is essential and obligatory to stimulate tumor or
tissue-infiltrating effector CD8
+ T cells. However, boosting a recall
immune response via memory CD8
+ T cells or vaccination to
stimulate naı ¨ve CD8
+ T cells would require CD28-mediated co-
stimulation.
Materials and Methods
Cell isolation, sorting and flow cytometry
PBMC were provided from healthy HLA-A2 blood donors by
the Sample Core of the Center for Human Immunology and
prepared by Ficoll-Hypaque density gradient. Isolation of
CD3
+CD8
+ T cells was done by negative selection using the
CD8
+ T cell Isolation Kit II (MACS, Miltenyi Biotec). Complete
RPMI consisting of 10% FCS, 2 mM L-Glutamine, 100 U/mL
penicillin, 100 mg/mL streptomycin and 50 mg/mL 2-mercapto-
ethanol was used throughout the study. For flow cytometry, cells
(2610
5) were stained in a final volume of 100 mL of FACS staining
buffer (1% bovine serum albumin (BSA), 0.04% w/v sodium azide
in PBS, pH 7.2). Antibodies to CD3, CD4, CD8, CD45RA,
CD27, CD28 and NKG2D were used at a final concentration of
1:100. FACS analyses were performed in LSRII (Becton
Dickinson) using FACSDiva software. Negative controls were
included in the assays wherever required. For sorting CD28
Hi and
CD28
Lo populations, CD8
+ T cells were negatively selected from
PBMC, stained for CD3, CD8 and CD28 and sorted in
FACSAria. Human lungs were obtained by the Sample Core
from HLA-A2 positive cadaveric organ donors when not needed
for transplantion. For isolating lymphocytes, lung tissue was
digested with collagenase and DNAse. Lymphocytes from the
digested tissue were isolated on a density gradient (Lymphocyte
separation medium, MP Biomedicals, Ohio). All protocols used in
this study were approved by the BloodCenter of Wisconsin
Institutional Review Board (IRB). Informed written consent was
obtained in accordance with the Declaration of Helsinki for
obtaining human samples.
T cell activation and quantification of cytokine
generation and cytotoxicity
Freshly isolated human PBMC or negatively selected CD8
+ Tc e l l s
were stimulated with plate-bound antibodies to CD3 (2.5 mg/mL),
CD28 (5.0 mg/mL) and NKG2D (5.0 mg/mL) alone or in combi-
nations. 50 mL of each antibody mix was prepared in ELISA coating
buffer (eBioscience, San Jose, CA) and coated on to ELISA plates
(Maxisorp,Nunc).1610
5PBMCorCD8
+Tc e ll sw e r ea d d e dt oe a c h
well in a final volume of 200 mL. Cells were incubated at 37uCf o r
18 h and the culture supernatants were collected and cytokines were
quantified using 27 or 7 Bio-Plex cytokine assay kits (BioRad,
Richmond, CA). For CD107a (LAMP1) surface expression, the T
cells were activated in the presence of monensin (1:1000) and anti-
CD107a for 4 h, and stained for the surface expression of CD3, CD8
and CD28.
Confocal microscopy
Lung and tracheal specimens were treated in 4% paraformal-
dehyde overnight. Tissue samples (,1c m
3) were embedded in
paraffin and 4 m thick sections were prepared and de-paraffinized
in xylene, and re-hydrated. Antigen unmasking was performed by
immersing slides in 10 mM sodium citrate buffer, pH 6.0 and
heating them at 95uC for 5 min. Slides were allowed to cool in the
buffer for approximately 20 min at room temperature. Tissue
sections were blocked with 3% BSA and Fc-Block (BD, San Jose,
CA) in PBS for 1 h. For analyzing the pentamer-positive cells for
their CD28 and NKG2D expression, the sections were incubated
with CD8-FITC, NKG2D-APC, CD28-PECy7 and GFL9/HLA-
A2 Pentamer-PE at a 1:100 dilution in 3% BSA overnight at 4uC.
For analyzing the expression of MICA, the ligand for NKG2D on
epithelial cells, the sections were incubated with pan-cytokeratin
(D12, unconjugated mouse monoclonal, Santa Cruz), E-Cadherin
(unconjugated rabbit anti-human antibody, Cell Signaling Tech-
nology, Beverly, MA) and MICA-APC (R&D systems, Minnea-
polis, MN) overnight at 4uC. Secondary antibodies to cytokeratin
(Goat anti-mouse Alexafluor 568, Molecular Probes, Invitrogen)
and E-cadherin (Donkey anti-rabbit Alexafluor 488, Molecular
Probes, Invitrogen) were added at a dilution of 1:500 in 3% BSA.
The sections were incubated for 30 min at room temperature and
washed with PBS. The sections were then mounted for confocal
microscopy (H-1000, VECTASHIELD Mounting medium for
fluorescence, Vector Laboratories Inc., San Diego, CA). For
analyzing the expression of CD28 and NKG2D on CD4
+ and
CD8
+ T cells in lung-derived lymphocytes were blocked with 3%
BSA and Fc-Block. Cells were then stained with CD8/CD4-FITC,
CD28-PECy7 and NKG2D-APC at a dilution of 1:100 in 3%
BSA for 30 min at 4uC. The cells were washed with PBS and
suspended in 20 ml of fixing buffer (1% FCS, 2.5% paraformal-
dehyde in PBS). The cells were mounted on Poly L-Lysine-coated
slides. The processed lung and tracheal sections and the lung-
derived lymphocytes were visualized using Olympus FluoView
FV1000 MPE multiple Laser Scanning Microscope with a 406oil
immersion objective.
Statistics
Statistical analyses were performed by two-tailed, paired t-test
or Student’s t-test. P values that are #0.05 were considered
significant.
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